NEXI — Neximmune Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Neximmune Inc - On October 25, Co Received Notice Of Delisting From Nasdaq
Brief: Neximmune Announces Research Collaboration With National Institute Of Neurological Disorders And Stroke
U.S. STOCKS ON THE MOVE-Bank stocks, Spar Group, Snap
U.S. STOCKS ON THE MOVE-Rivian, Intapp, Maxeon Solar Technologies
NexImmune jumps on drug development agreement with Selexis SA
Brief: Selexis And Neximmune Sign Service Agreement To Advance Multiple Immunotherapies Targeting Rare Cancers And Autoimmune Disorders
Brief: NexImmune Reports Q2 2022 Results And Highlights FDA Clearance Of IND For NEXI-003 For Treatment Of HPV-Related Cancers
U.S. STOCKS ON THE MOVE-Neximmune Inc, Zymeworks Inc,
Neximmune surges on FDA nod for HPV-related cancer therapy
Brief: NexImmune Reports IND Clearance by FDA for NEXI-003
Brief: Neximmune Inc - To Offer And Sell Shares Of Its Common Stock, Having An Aggregate Offering Price Of Up To $50 Million
U.S. RESEARCH ROUNDUP-Blueprint Medicines, Sealed Air, Tempur Sealy
Neximmune Inc reports results for the quarter ended in March - Earnings Summary
Brief: NexImmune Reports First Quarter 2022 Financial Results And Provides Business Updates
Brief: Neximmune, Yale, And JDRF Enter Into Research Partnership For Type 1 Diabetes
Brief: Neximmune Announces Appointment Of Dr. Leena Gandhi To Its Board Of Directors
Brief: NexImmune Collaborates with Herbert Irving Comprehensive Cancer Center
Brief: Neximmune Promotes Mathias Oelke To Chief Scientific Officer
Brief: Neximmune, Zephyr Ai Announce Strategic Partnership In Oncology For Target Discovery And Validation